[Immunglobulin Substitution Therapy in Hematological Patients with secondary Antibody Deficiency].
Publisher DOI
PubMed ID
35903825
Abstract
Immunglobulin Substitution Therapy in Hematological Patients with secondary Antibody Deficiency Abstract. Hematological malignancies and immunochemotherapy are frequently associated with secondary cellular and humoral immunodeficiencies. Due to the growing application of effective therapeutic antibodies, and cellular therapies specifically targeting and hence depleting antibody producing cells (B- and plasma cells) the incidence of secondary antibody deficiencies in the daily practice is increasing. This article will provide a short overview of the etiology of secondary antibody deficiencies in hematological patients. Then, it will discuss the efficacy and indication of immunoglobulin substitution therapy in these patients and finally address the choice of the respective preparation.
Date Issued
2022-08
Publication Type
Article
Subject(s)
Language(s)
de
Author(s)
Additional Credits
Journal
Therapeutische Umschau
Publisher
Hogrefe
ISSN
0040-5930
Access(Rights)
restricted